Spend Analytics

Five Spend Analysis Benefits Pharmaceutical Executives Should Know About

6 min read
Akshay Upadhye
Co-Founder
Spend Analytics
5 min read

Five Spend Analysis Benefits Pharmaceutical Executives Should Know About

Written by
Akshay Upadhye
Published on
As per a report from McKinsey “Predictive analytics and data visualisation offer pharma business leaders the opportunity to transform commercial-spend optimisation and lift returns by 10 to 25 percent.”

Spend analysis, is often overlooked in pharma, but when accurately performed, it is integral to understand the organisation and can lead to surprising, yet meaningful insights. Such insights can be a catalyst to informed change, delivering organisation-wide efficiencies and cost savings. Using a spend analysis solution such as Spendkey, allows pharmaceuticals to bring together their often-fragmented raw data and uncover the hidden potential lying within. This can result in sustained, bottom-line impact and enhanced risk management strategies.

Pharmaceutical Executives sponsoring such projects will be able to harness the following benefits:

Normalising the data

Spendkey knows how fragmented and disparate pharmaceutical spend data can be. As the first, fully automated solution Spendkey can normalise multiple sources of raw data into meaningful insights quickly and accurately, with potential to make significant impact to the organisation’s bottom-line. Traditionally this process of “data normalisation” – i.e. the extraction, cleansing, classifying and standardising of the data - has been manual. As a result it has been time-consuming, inconsistent and full of errors. With Spendkey it’s automated, and with Mundi Pharma hundreds of thousands of transactions were processed, normalised and turned into significant insights within two weeks. From this Mundi Pharma was able to calculate and claim substantial rebates in the first fifteen minutes of getting access to the dashboard.

If you too want to normalise your data - contact us at info@spendkey.co.uk or alex@spendkey.co.uk

Payment savings


Spendkey recognises that Pharmaceutical Executives are under immense pressure to both reduce material costs and increase profits. Spendkey can provide insights into both spending patterns and supplier profiles. As part of the spend analysis report, Spendkey can provide the insights to be able to implement control over the pharmaceutical’s operational activities. Spendkey has helped pharmaceuticals avoid late payments and the associated penalty fees, plus has been able to identify and evade duplicate payments. Moreover, Spendkey can improve working-capital benefit by identifying where payments terms can be extended.

If you too want to normalise your data - contact us at info@spendkey.co.uk or alex@spendkey.co.uk

Experienced resources


Pharma purchasing teams may be focused on their daily tasks such as buying the ingredients and materials required by the organisation. Spend analysis is a strategic sourcing process to drive leverage across the entire organisation. Spendkey is experienced in supporting pharmaceuticals in driving most value from their data sets and delivering real benefits in supply chain efficiency. For example, Spendkey’s analysis report provided real-time insights into a pharma’s procurement activities and expenditures. This identified multiple suppliers being paid for the same materials across the divisions and sub-divisions of the organisaton.  Subsequently Spendkey was able to reduce the pharma’s costs through consolidation of suppliers and negotiation of significant price reductions. As a direct result the pharma’s profitability increased by over 10%.

If you too want to normalise your data - contact us at info@spendkey.co.uk or alex@spendkey.co.uk

Risk management


With Spendkey, pharmaceuticals can observe dependency on key suppliers by determining the level of dealings with them. The in-depth spend analysis which Spendkey provides helps pharmaceuticals to advance their risk management strategies. It is possible to distinguish core suppliers and identify where there may be over-reliance. Consequently, alternative sources can be secured to reduce dependency on certain providers. Effective risk mitigation in pharma can not only be converted into direct savings fast but can also make the supply chain more resilient and able to sustain change.

If risk management is a constant concern, we can help - contact us at info@spendkey.co.uk or alex@spendkey.co.uk

Organisation growth

The data obtained through Spendkey and the spend analysis outputs, enable Executives to secure the benefits of a reliable supply chain which in turn gives them the capacity to scale up, or consider M&A opportunities, or enter profitable ventures.

To know more about how spend analysis can benefit your organisation - contact us at info@spendkey.co.uk or alex@spendkey.co.uk

To summarise

Given the complex global, regulated and demanding environment that pharmaceutical companies operate, optimising your commercial spend is not easy; it takes investment in new processes, capabilities, and, in some cases, technology. It also requires a new organisation culture about making business decisions based on data. The change, however, is worth it: companies that have fully embraced the new, integrated approach to commercial-spend optimisation have seen improvements in returns of 10 to 25 percent during the first year of implementation. With further tuning, these can rise even higher.

Subscribe to receive the latest blog posts to your inbox every week.

By subscribing you agree to with our Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
As per a report from McKinsey “Predictive analytics and data visualisation offer pharma business leaders the opportunity to transform commercial-spend optimisation and lift returns by 10 to 25 percent.”

Spend analysis, is often overlooked in pharma, but when accurately performed, it is integral to understand the organisation and can lead to surprising, yet meaningful insights. Such insights can be a catalyst to informed change, delivering organisation-wide efficiencies and cost savings. Using a spend analysis solution such as Spendkey, allows pharmaceuticals to bring together their often-fragmented raw data and uncover the hidden potential lying within. This can result in sustained, bottom-line impact and enhanced risk management strategies.

Pharmaceutical Executives sponsoring such projects will be able to harness the following benefits:

Normalising the data

Spendkey knows how fragmented and disparate pharmaceutical spend data can be. As the first, fully automated solution Spendkey can normalise multiple sources of raw data into meaningful insights quickly and accurately, with potential to make significant impact to the organisation’s bottom-line. Traditionally this process of “data normalisation” – i.e. the extraction, cleansing, classifying and standardising of the data - has been manual. As a result it has been time-consuming, inconsistent and full of errors. With Spendkey it’s automated, and with Mundi Pharma hundreds of thousands of transactions were processed, normalised and turned into significant insights within two weeks. From this Mundi Pharma was able to calculate and claim substantial rebates in the first fifteen minutes of getting access to the dashboard.

If you too want to normalise your data - contact us at info@spendkey.co.uk or alex@spendkey.co.uk

Payment savings


Spendkey recognises that Pharmaceutical Executives are under immense pressure to both reduce material costs and increase profits. Spendkey can provide insights into both spending patterns and supplier profiles. As part of the spend analysis report, Spendkey can provide the insights to be able to implement control over the pharmaceutical’s operational activities. Spendkey has helped pharmaceuticals avoid late payments and the associated penalty fees, plus has been able to identify and evade duplicate payments. Moreover, Spendkey can improve working-capital benefit by identifying where payments terms can be extended.

If you too want to normalise your data - contact us at info@spendkey.co.uk or alex@spendkey.co.uk

Experienced resources


Pharma purchasing teams may be focused on their daily tasks such as buying the ingredients and materials required by the organisation. Spend analysis is a strategic sourcing process to drive leverage across the entire organisation. Spendkey is experienced in supporting pharmaceuticals in driving most value from their data sets and delivering real benefits in supply chain efficiency. For example, Spendkey’s analysis report provided real-time insights into a pharma’s procurement activities and expenditures. This identified multiple suppliers being paid for the same materials across the divisions and sub-divisions of the organisaton.  Subsequently Spendkey was able to reduce the pharma’s costs through consolidation of suppliers and negotiation of significant price reductions. As a direct result the pharma’s profitability increased by over 10%.

If you too want to normalise your data - contact us at info@spendkey.co.uk or alex@spendkey.co.uk

Risk management


With Spendkey, pharmaceuticals can observe dependency on key suppliers by determining the level of dealings with them. The in-depth spend analysis which Spendkey provides helps pharmaceuticals to advance their risk management strategies. It is possible to distinguish core suppliers and identify where there may be over-reliance. Consequently, alternative sources can be secured to reduce dependency on certain providers. Effective risk mitigation in pharma can not only be converted into direct savings fast but can also make the supply chain more resilient and able to sustain change.

If risk management is a constant concern, we can help - contact us at info@spendkey.co.uk or alex@spendkey.co.uk

Organisation growth

The data obtained through Spendkey and the spend analysis outputs, enable Executives to secure the benefits of a reliable supply chain which in turn gives them the capacity to scale up, or consider M&A opportunities, or enter profitable ventures.

To know more about how spend analysis can benefit your organisation - contact us at info@spendkey.co.uk or alex@spendkey.co.uk

To summarise

Given the complex global, regulated and demanding environment that pharmaceutical companies operate, optimising your commercial spend is not easy; it takes investment in new processes, capabilities, and, in some cases, technology. It also requires a new organisation culture about making business decisions based on data. The change, however, is worth it: companies that have fully embraced the new, integrated approach to commercial-spend optimisation have seen improvements in returns of 10 to 25 percent during the first year of implementation. With further tuning, these can rise even higher.

Download our free Category Management Template

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Download our free Category Management Template

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Akshay Upadhye
Co-Founder
Akshay solves the biggest challenges faced by organizations as they digitally transform and establish a reputation for delivery. His contribution enables the business to realize a sustainable market competitive advantage, measured tangibly onto the business bottom line. His reputation is underpinned by a cumulative experience exceeding 22 years where he has been engaged by both small niche businesses to private equity-owned entities and world recognised brands.

More news

Spend Analytics

Growing your business with payment analytics and insights

Payment Analytics is the process of integrating and analysing payments data from different sources like bank transfers, credit cards, employee expenses

Read Article
Cost Optimization

What is maverick spend and how you can control it successfully?

An organisation that is not taking any action on their maverick spend will always lack the visibility of what your employees/business is spending and whom it is spending with to buy what products and services. Without this knowledge, organisations will be unable to risk assess the impact of this maverick spend.

Read Article
Spend Analytics

Spend Category Management & its Benefits in Procurement

Category Management helps to organise the procurement team resources and contributes towards economies of scale and enhanced supplier relationships whilst gaining an in-depth understanding of how each category contributes to risk management.

Read Article